Home › Research › Long-term cohort studies
The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study
Craig Ritchie, Dominic Trépel, Sophie J. Edwards, Julie Hviid Hahn-Pedersen, Mei Sum Chan, Benjamin Bray, Alice Jessie Clark, Christian Ahmad Wichmann et al.. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, 2025-04-01
Topic: Risk, prevention and care in population studies
Plain-language summary
Of 164,508 eligible participants, 6605(4%) had cognitive testing scores consistent with MCI. Ten-year inpatient costs were 7.6% higher in MCI versus matched no-MCI participants, while 6-year primary care costs were 9.1% higher. Among MCI participants, AD dementia incidence rates were substantially higher than in non-MCI participants (7.2 5-year incidence rate ratio 95% CI: 3.3 to 15.7), and eventual AD dementia accrued higher additional inpatient costs (mean £20,199) over 10 years. MCI is characterized by modestly higher healthcare utilization and costs. Subsequent AD dementia diagnosis was strongly associated with costs. Highlights: Baseline cognitive tests identified individuals with all-cause MCI in the UK Biobank.We compared individuals with MCI to propensity score-matched participants without MCI.Inpatient costs were 7.6% higher over 10 years, and primary care costs were 9.1% higher over 6 years for participants with MCI.AD dementia incidence rate ratio was 7.2 higher in participants with MCI.Among MCI participants, eventual AD dementia was a key driver of costs resulting in higher inpatient costs (mean £20,199) over 10 years.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. In this UK Biobank study, people with mild cognitive impairment had modestly higher healthcare costs and a much higher rate of later Alzheimer's disease dementia than those without MCI. Reported effect size: 7.6%; 9.1%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Ritchie, C., Trépel, D., Edwards, S. J., Hahn-Pedersen, J. H., Chan, M. S., Bray, B., et al. (2025). The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. https://doi.org/10.1002/dad2.70065
Vancouver
Ritchie C, Trépel D, Edwards SJ, Hahn-Pedersen JH, Chan MS, Bray B, et al. The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study. Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring. 2025. doi:10.1002/dad2.70065. PMID: 40510591.
BibTeX
@article{ritchie2025-40510591,
author = {Ritchie, Craig and Trépel, Dominic and Edwards, Sophie J. and Hahn-Pedersen, Julie Hviid and Chan, Mei Sum and Bray, Benjamin and Clark, Alice Jessie and Wichmann, Christian Ahmad and others},
title = {{The impact of mild cognitive impairment on healthcare utilization and costs: A UK Biobank study}},
journal = {Alzheimer s \& Dementia Diagnosis Assessment \& Disease Monitoring},
year = {2025},
doi = {10.1002/dad2.70065},
pmid = {40510591},
url = {https://doi.org/10.1002/dad2.70065}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Of 164,508 eligible participants, 6605(4%) had cognitive testing scores consistent with MCI.
- Ten-year inpatient costs were 7.6% higher in MCI versus matched no-MCI participants, while 6-year primary care costs were 9.1% higher.
- Among MCI participants, AD dementia incidence rates were substantially higher than in non-MCI participants (7.2 5-year incidence rate ratio 95% CI: 3.3 to 15.7), and eventual AD dementia accrued higher additional inpatient costs (mean £20,199) over 10 years.
- MCI is characterized by modestly higher healthcare utilization and costs.
- Subsequent AD dementia diagnosis was strongly associated with costs.
Why it matters
In this UK Biobank study, people with mild cognitive impairment had modestly higher healthcare costs and a much higher rate of later Alzheimer's disease dementia than those without MCI. The findings describe costs and diagnosis patterns, not any treatment or way to prevent dementia.
Study details
- Study designcohort study
- Effect size7.6%; 9.1%
- Evidence strengthModerate
How this study scored 49/100
Published in a peer-reviewed journal, and it is a cohort study following people over time. Scored zero for sample size, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring) |
| Journal's citation record | 1 / 4 | Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring: journal h-index 86 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 4 times (OpenAlex, 2026-10-10) |
| Citations per year | 1 / 5 | 1.3 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 2.5× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 1 / 6 | Cited by 1 other studies in this library |
| Still being cited | 1 / 4 | Cited 4 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Marc Evans: h-index 45 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Trinity College Dublin: institution h-index 926 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 5 institution(s) in 3 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40510591) |
| Free to read | 2 / 2 | Free to read |
| Total | 49 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.1002/dad2.70065
- PubMed: 40510591
- Original source →
- Free full text: Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here. Showing 12 of 15.
Later studies that cite this one
1 study in the alzhub library lists this one in its references.
Related studies in Long-term cohort studies from nearby years
Also tagged “mini-mental”
840 studies in the library carry the topic tag “mini-mental”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 840 tagged studies.